Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yoshihara

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2026
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working GroupShun-Ichi Kimura, Kazuki Yoshimura, Hideki Nakasone, et al.
Haematologica|September 11, 2025
Age-related differences in donor selection priorities for allogeneic hematopoietic transplantationKoji Kawamura, Junya Kanda, Sachiko Seo, et al.
American Journal of Hematology|May 19, 2025
Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry AnalysisKyoko Masuda, Keisuke Kataoka, Masatoshi Sakurai, et al.
Leukemia|December 21, 2023
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remissionMasamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, et al.
International Journal of Hematology|May 4, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 yearsMasamitsu Yanada, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
Transplantation and Cellular Therapy|April 23, 2022
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell TherapyTomoyasu Jo, Satoshi Yoshihara, Asuka Hada, et al.
International Journal of Hematology|May 20, 2025
Safety of hematopoietic stem cell donation from young related donors following the lowering of the age of legal adulthood in JapanTsuneaki Hirakawa, Hiromasa Yabe, Masayuki Hino, et al.
Annals of Hematology|May 15, 2024
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemiaYukinori Nakamura, Yoshitaka Zaimoku, Hiroki Yamaguchi, et al.
Transplantation|June 28, 2003
Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitutionKunihisa Nakai, Shin Mineishi, Masahiro Kami, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2026
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working GroupShun-Ichi Kimura, Kazuki Yoshimura, Hideki Nakasone, et al.
Haematologica|September 11, 2025
Age-related differences in donor selection priorities for allogeneic hematopoietic transplantationKoji Kawamura, Junya Kanda, Sachiko Seo, et al.
American Journal of Hematology|May 19, 2025
Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry AnalysisKyoko Masuda, Keisuke Kataoka, Masatoshi Sakurai, et al.
Leukemia|December 21, 2023
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remissionMasamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, et al.
International Journal of Hematology|May 4, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 yearsMasamitsu Yanada, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
Transplantation and Cellular Therapy|April 23, 2022
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell TherapyTomoyasu Jo, Satoshi Yoshihara, Asuka Hada, et al.
International Journal of Hematology|May 20, 2025
Safety of hematopoietic stem cell donation from young related donors following the lowering of the age of legal adulthood in JapanTsuneaki Hirakawa, Hiromasa Yabe, Masayuki Hino, et al.
Annals of Hematology|May 15, 2024
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemiaYukinori Nakamura, Yoshitaka Zaimoku, Hiroki Yamaguchi, et al.
Transplantation|June 28, 2003
Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitutionKunihisa Nakai, Shin Mineishi, Masahiro Kami, et al.
Pageof 15